Market Place
Sourcing Support
SK Bioscience, IDT, Vaxxas Picked for EU Flu Vaccine Program
26 Feb 2026 //
PR NEWSWIRE
SK Bioscience Licenses RSV Preventive Mab From Gates Medical
03 Feb 2026 //
PR NEWSWIRE
SK Bioscience Advances Universal Sarbecovirus Vaccine to Phase
29 Jan 2026 //
PR NEWSWIRE
SK Bioscience, MSD, Hilleman Labs Advance Ebola Vaccine
22 Jan 2026 //
PR NEWSWIRE BIO
IDT Biologika Expands CDMO Globally at WVC, CPHI & Bio-Europe
05 Nov 2025 //
PR NEWSWIRE
Sunflower Therapeutics Get Payment from SK Bio for HPV Vaccine
18 Sep 2025 //
BUSINESSWIRE
SK Bioscience Submits IND for Phase 3 Varicella Vaccine Trial
02 Sep 2025 //
PR NEWSWIRE
SK Bioscience, Gates Foundation Plan More Global Health Projects
21 Aug 2025 //
PR NEWSWIRE
SK Bioscience, KDCA Launch Flu Program to Shield South Korea
26 May 2025 //
EXPRESSPHARMA
SK defeats Pfizer in Korean patent feud
22 May 2025 //
FIERCE PHARMA
IDT Biologika Partners for Global Growth Acceleration
21 May 2025 //
CONTRACTPHARMA
SK Bioscience Starts Global Trials of mRNA Japanese Encephalitis
27 Feb 2025 //
PR NEWSWIRE
SK Bio Approved For Global Trials Of mRNA Encephalitis Vaccine
12 Dec 2024 //
PRESS RELEASE
SK Bio Receives Minister of Trade, Industry & Energy Award
29 Nov 2024 //
PRESS RELEASE
SK Bioscience Receives Approval For Quadrivalent Influenza Vaccine
23 Oct 2024 //
PRESS RELEASE
SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions
08 Oct 2024 //
PRESS RELEASE
SK bioscience Completes Acquisition of IDT Biologika
02 Oct 2024 //
PRESS RELEASE
Novavax COVID-19 Vaccine Expands Options, Approved For Use
30 Sep 2024 //
PRESS RELEASE
SK Bioscience And CEPI Deepen Partnership For Pandemic Preparedness
30 Aug 2024 //
PRESS RELEASE
SK Bioscience Signs SAFE With U.S. Biotech Sunflower
25 Jul 2024 //
PRESS RELEASE
SK bioscience Signs Power Purchase Agreement with SK E&S
16 Jul 2024 //
PRESS RELEASE
SK bioscience Exports Influenza Vaccine to Thailand, Southern Hemisphere
21 Mar 2024 //
PRESS RELEASE
SK bioscience exports influenza vaccine to Thailand, entering Southern market
21 Mar 2024 //
BIOSPECTRUM ASIA
SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine
23 Feb 2024 //
PR NEWSWIRE
PM of the Republic of Serbia Visits SK bioscience for Vaccine Localization
08 Sep 2023 //
PR NEWSWIRE
Australia-Korea joint devp agreement for needle-free of typhoid vaccine
29 Aug 2023 //
BIOSPECTRUM ASIA
SK bioscience Announces Equity Investment in Novavax to Strengthen Partnership
08 Aug 2023 //
PR NEWSWIRE
Novavax to sell 7% stake to South Korea`s SK Bioscience
08 Aug 2023 //
REUTERS
Korea`s SK inks deal to support vaccine production in Thailand
05 Jul 2023 //
FIERCE PHARMA
SK bioscience-Sanofi Announce Positive Results from Ph II Study of 21-Valent
29 Jun 2023 //
PR NEWSWIRE
SK bioscience, Peter Doherty Institute Partner on Influenza Research
26 Jun 2023 //
CONTRACT PHARMA
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the WHO
19 Jun 2023 //
PR NEWSWIRE
SK bioscience COVID-19 Vaccine Granted Emergency Use by WHO
19 Jun 2023 //
CONTRACT PHARMA
SK bioscience Receives Marketing Authorization of COVID-19 Vaccine from UK MHRA
30 May 2023 //
PR NEWSWIRE
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
30 May 2023 //
PHARMACEUTICAL TECHNOLOGY
SK bioscience Presents Solution for Equitable Access of Vaccine
23 May 2023 //
PR NEWSWIRE
SK bioscience Establishes Songdo Research & Process Development Center
09 Feb 2023 //
CONTRACT PHARMA
SK Bioscience plans $261M expansion in South Korea with new facility
09 Feb 2023 //
ENDPTS
SK bioscience to Establish a Vaccine-Biopharma Hub
09 Feb 2023 //
CONTRACT PHARMA
Readying for next pandemic, Korea`s SK pumps $261M into R&D site
08 Feb 2023 //
FIERCE BIOTECH
SK bioscience Introduces New Global Partnership Model for Vaccines
27 Jan 2023 //
CONTRACT PHARMA
SK bioscience`s Zoster Vaccine Receives BLA Approval in Malaysia
09 Jan 2023 //
PR NEWSWIRE
